Artal Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2023
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $1.95M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $5.77M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $6.05M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $4.75M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $6.48M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $11.4M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $13.5M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $12.1M | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $14.1M | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q3  | $10.9M | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q2  | $13M | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q1  | $10.4M | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q4  | $12.5M | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q3  | $10.4M | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q2  | $9.15M | Buy | 
         | 
    |||||
| 
        
          
      
        2019
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q4  | $1.02M | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q3  | $3.98M | Buy | 
         |